Abstract
Background: Despite the fact that reduction mammaplasty is an effective and efficient treatment to symptomatic macromastia, frequently, women demanding this treatment are accepted or not depending on body mass index criteria. The aim of this work was to compare changes of quality of life on obese and no-obese women who undergoing breast reduction mammaplasty. Methods: A prospective study was performed on 56 consecutive women undergoing bilateral reduction mammaplasty for symptomatic macromastia, 21 of them had a BMI lower than 30 (No-obese group) and 35 with 30 or higher BMI (Obese group). Short Form SF-36 quality of life questionnaires were answered at interviews a week before the surgery and six months after. To evaluate the change of quality of life we used “effect size”. Results: Preoperative SF36 scores did not make differences between both groups. Six months after surgery only postoperative physical score of no-obese patients was significantly higher than obese one (52.11 vs 48.47, p>0.05). Both groups increased clearly their quality of life showing an increment of all SF36 domains with an effect size ranged from 0.53 to 2.07. More than seventy percent of obese women improved their scores exceeding means of preoperative scores. Conclusion: According to our results and the fact that the main goal of the breast reduction is ameliorate the quality of life there is no justification for exclusion obese patients with BMI >30 who suffer from symptomatic macromastia from reduction mammaplasty. Therapy: Level III of Evidence. Keywords: Reduction mammaplasty, Symptomatic macromastia, Obese, SF-36 health questionnaire, Effect size.
Highlights
Reduction mammaplasty (RM) and obesity is a frequent topic but most published articles are concerned with early surgical complications in those obese patients who undergoing a RM for symptomatic macromatia (SM) describing frequently an increment of the risks of complications in this group of patient
Some articles [10,11,12,13,14] comment that these patients improved significantly their quality of life after breast reduction with the same extent as do those who are at normal weight, there is a paucity of designed studies for the particular purpose of evaluate the effect of RM on obese patient and to compare them with those caused on no-obese patients
Obese patients had a major proportion of comorbidities such as diabetes mellitus, arterial hypertension, asthma (31%) and the fact that the amount of breast tissue removed was higher than no-obese patients with an average difference of 376 grams, so their breasts must have been quite larger, SF-36 domains scores did not make differences statistically significant between both groups
Summary
Reduction mammaplasty (RM) and obesity is a frequent topic but most published articles are concerned with early surgical complications in those obese patients who undergoing a RM for symptomatic macromatia (SM) describing frequently an increment of the risks of complications in this group of patient. Some articles [10,11,12,13,14] comment that these patients improved significantly their quality of life after breast reduction with the same extent as do those who are at normal weight, there is a paucity of designed studies for the particular purpose of evaluate the effect of RM on obese patient and to compare them with those caused on no-obese patients. Despite the fact that reduction mammaplasty is an effective and efficient treatment to symptomatic macromastia, frequently, women demanding this treatment are accepted or not depending on body mass index criteria. The aim of this work was to compare changes of quality of life on obese and no-obese women who undergoing breast reduction mammaplasty
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
